McDonald L C, Banerjee S N, Jarvis W R
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Infect Control Hosp Epidemiol. 1998 Oct;19(10):772-7. doi: 10.1086/647722.
To determine risk factors for an increase in line-associated bloodstream infections (BSIs) in three pediatric intensive-care units at one hospital that recently had changed brands of needleless access device.
Retrospective case-control studies; review of the units' infection control policies and procedures for accessing and replacing components of needleless access devices.
A community tertiary-care hospital's three pediatric intensive-care units.
Children in one of the three intensive-care units with a central venous catheter in place during January 1, 1995, through May 15, 1996, who developed laboratory-confirmed primary BSI. Children who had central venous catheters in place for >48 hours and who did not develop BSI were chosen randomly as controls.
Eight patients met the case definition; they had 11 episodes of BSI. Multivariate analysis identified duration of catheterization and exposure to the IVAC first-generation needleless device as independent risk factors for BSI. Compared with patients from another pediatric intensive-care unit in which the IVAC device also was used but in which an increased BSI rate did not occur, patients from the unit with an increased BSI rate were more likely to receive intermittent (vs continuous) intravenous therapy through one or more lumens. In both units, the IVAC device valve component was replaced every 6 days, and the endcap used to cover the valve (when connected to an unused lumen) was replaced every 24 hours or after each access. The BSI rate returned to baseline after institution of a policy to replace the entire IVAC device, valve, and endcap every 24 hours.
An increased risk of BSI was associated with use of the IVAC first-generation needleless device when replaced every 6 days. This increased risk may have been more pronounced in one pediatric intensive-care unit, because patients were more likely to receive intermittent intravenous therapy. Intermittent intravenous therapy or central venous catheter flushing practices may be important determinants of BSI risk.
确定一家医院的三个儿科重症监护病房中与导管相关血流感染(BSI)增加的危险因素,该医院最近更换了无针接入装置的品牌。
回顾性病例对照研究;审查各病房关于无针接入装置组件接入和更换的感染控制政策及程序。
一家社区三级护理医院的三个儿科重症监护病房。
1995年1月1日至1996年5月15日期间在三个重症监护病房之一留置中心静脉导管且实验室确诊为原发性BSI的儿童。随机选择留置中心静脉导管超过48小时且未发生BSI的儿童作为对照。
8例患者符合病例定义;他们发生了11次BSI发作。多变量分析确定导管插入持续时间和接触IVAC第一代无针装置是BSI的独立危险因素。与另一个也使用IVAC装置但BSI发生率未增加的儿科重症监护病房的患者相比,BSI发生率增加的病房的患者更有可能通过一个或多个管腔接受间歇性(而非持续性)静脉治疗。在两个病房中,IVAC装置的瓣膜组件每6天更换一次,用于覆盖瓣膜(当连接到未使用的管腔时)的端帽每24小时或每次接入后更换。在实施每24小时更换整个IVAC装置、瓣膜和端帽的政策后,BSI发生率恢复到基线水平。
每6天更换一次的IVAC第一代无针装置的使用与BSI风险增加相关。这种增加的风险在一个儿科重症监护病房可能更为明显,因为患者更有可能接受间歇性静脉治疗。间歇性静脉治疗或中心静脉导管冲洗操作可能是BSI风险的重要决定因素。